TheEdgeResearch
Home / Stocks / IBXNF

IBEX Technologies Inc. (IBXNF)

OTC Healthcare Biotechnology
$1.00 ▼ -6.54%
Market Cap
$25.3M
Sector
Healthcare
Industry
Biotechnology
Beta
-0.04
52-Wk Range
0.56-1.1
CEO
Paul Baehr
Country
CA
Currency
USD

IBEX Technologies Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Montreal, QC, CA. The stock last traded at $1.00, down 6.54% on the session, giving a market capitalisation of $25.3M. On trailing twelve-month figures it carries a trailing P/E of 8.96, a net margin of 52.0%. Its beta of -0.04 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
8.96
Price / Sales
4.84
Price / Book
2.61
EV / EBITDA
11.09
Gross margin
69.4%
Operating margin
-19.8%
Net margin
52.0%
Return on equity
—
Debt / equity
0.12
Current ratio
5.69
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2018-08-24
Headquarters
Montreal, QC, CA
About IBEX Technologies Inc.

Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc. specializes in the production and global distribution of enzymes tailored for biomedical applications. The company's reach extends to Canada, the United States, Germany, and the United Kingdom, as well as other international markets. Its extensive product catalog features recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, along with Chondroitinase AC and B. Furthermore, IBEX offers collagen ELISAs designed to investigate the synthesis and breakdown of connective tissue components, complementing these with collagen antibodies and diamine oxidase liquid. They are also a key provider of arthritis assays, essential for research into osteoarthritis. Beyond their product lines, IBEX delivers lyophilization services for disposable medical device parts, in addition to custom fermentation and contract manufacturing capabilities. Their diverse client base encompasses medical device fabricators, quality control facilities, producers of low molecular weight heparin, and academic research institutions.

Comparable companies

IBEX Technologies Inc. is most often compared with the following Healthcare names:

EMMLFGENHIGXTIMMPFKMSTFMKEAFOCELOPBXFRDTCFVBIO
More research on IBXNF
IBXNF technical analysis IBXNF TheEdge Score Compare against peers
Open full interactive analysis & DCF →